Skip to main content

Table 1 Patient characteristics

From: Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients

  

n

%

Histology

   
 

NST

131

57.7

 

non NST

96

42.3

Grading

   
 

G1. G2

103

66.0

 

G3

53

34.0

pT

   
 

pT1

153

68.0

 

pT2-pT4

72

32.0

pN

   
 

pN0

122

56.7

 

pN1-pN3

93

43.3

CIS (fraction within the invasive carcinoma)

   
 

no

107

47.1

 

yes

120

52.9

ER

   
 

negative

30

14.6

 

positive

175

85.4

PR

   
 

negative

62

32.6

 

positive

128

67.4

Her2

   
 

negative

160

88.9

 

positive

20

11.1

age (years)

   
 

mean ± STDV

58.2 ± 13.3